Article info
PDFResearch paper
The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy
- Dr Suvi Liimatainen, Hirvenkellontie 7 A 1, 37560 Lempäälä, Finland; suvi.liimatainen{at}fimnet.fi
Citation
The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy
Publication history
- Received August 19, 2007
- Revised October 17, 2007
- Accepted October 18, 2007
- First published November 8, 2007.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group